Early and late cognitive event-related potentials mark stages of HIV-1 infection in the drug-user risk group.

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Early and late cognitive event-related potentials mark stages of HIV-1 infection in the drug-user risk group.

Biol Psychiatry. 1994 Jan 1;35(1):54-69. Unique Identifier : AIDSLINE MED/94220545
Schroeder MM; Handelsman L; Torres L; Dorfman D; Rinaldi P; Jacobson J; Wiener J; Ritter W; Psychiatry Services, Veteran Affairs Medical Center, Bronx, NY; 10468.

Abstract: HIV-1 (Human immunodeficiency virus) infection of the brain causes delays in auditory event-related potential (ERP) components. We recorded auditory ERPs from 38 former parenteral drug users (PDUs) at three stages of HIV-1 infection: seronegative; seropositive; stage II; and seropositive, stage IV. There were five response conditions: Go Nogo, Count, Simple Response, Simple Count, and Ignore. P3 peak latencies were significantly delayed and P3 amplitudes were significantly reduced for all seropositives, including asymptomatics, when compared to PDU seronegative controls. In contrast, the P1 and N1 peak latency measures were delayed only for seropositives with acquired immunodeficiency syndrome (AIDS) qualifying illnesses. There was a significant negative correlation between the CD4 count and the latency of P1, N1, and the MMN. Also, increased P1 and N1 amplitudes correlated with indices of disease progression (Choice RT and CD4 counts, respectively). The results extend previous findings by clarifying the pattern of auditory ERP markers of disease progression. Early, as well as late, brain involvement caused by HIV-1 is marked by delays and decreased amplitudes in cognitive components. In addition, late brain involvement is marked by delays and increased amplitudes in specific, automatic, and/or obligatory components.

Keywords: Acquired Immunodeficiency Syndrome/DIAGNOSIS/*PHYSIOPATHOLOGY Adult Attention/PHYSIOLOGY AIDS Dementia Complex/DIAGNOSIS/*PHYSIOPATHOLOGY/PSYCHOLOGY AIDS-Related Opportunistic Infections/DIAGNOSIS/PHYSIOPATHOLOGY/ PSYCHOLOGY Cerebral Cortex/PHYSIOPATHOLOGY Evoked Potentials, Auditory/*PHYSIOLOGY Human HIV Seropositivity/DIAGNOSIS/PHYSIOPATHOLOGY/PSYCHOLOGY HIV-1 Male Middle Age Pitch Discrimination/PHYSIOLOGY Reaction Time/PHYSIOLOGY Substance Abuse, Intravenous/COMPLICATIONS/DIAGNOSIS/ *PHYSIOPATHOLOGY Support, U.S. Gov't, Non-P.H.S. JOURNAL ARTICLE
940830
M9480763

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .